Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Annelien J.A. Schulp"'
Autor:
Bob Oranje, Dorinde M. van Andel, Jan J. Sprengers, Nicolaas P.A. Zuithoff, Hilgo Bruining, Annelien J.A. Schulp, Mandy G. Keijzer-Veen, Marc R. Lilien, Floortje E. Scheepers
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry, 60(7), 865-876. Elsevier Limited
Sprengers, J, Van Andel, D M, Zuithoff, N P A, Keijzer-Veen, M G, Schulp, A J A, Scheepers, F E, Lilien, M R, Oranje, B & Bruining, H 2021, ' Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI) : A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial ', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 60, no. 7, pp. 865-876 . https://doi.org/10.1016/j.jaac.2020.07.888
Sprengers, J, Van Andel, D M, Zuithoff, N P A, Keijzer-Veen, M G, Schulp, A J A, Scheepers, F E, Lilien, M R, Oranje, B & Bruining, H 2021, ' Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI) : A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial ', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 60, no. 7, pp. 865-876 . https://doi.org/10.1016/j.jaac.2020.07.888
Objective: Recent trials have indicated positive effects of bumetanide in autism spectrum disorder (ASD). We tested efficacy of bumetanide on core symptom domains using a single center, parallel-group, participant-randomized, double-blind, placebo-co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b834e8d32b63537676e5cee93e096d
https://doi.org/10.1016/j.jaac.2020.07.888
https://doi.org/10.1016/j.jaac.2020.07.888
